Search - tctmd.com

Displaying 101 - 120 of 249

Sort: Relevancy | Date

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation SOLACI 2016

The Unmet Needs of DES

Presenter: Roxana Mehran

June 09, 2016

Presentation Fellows 2016

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Roxana Mehran

April 15, 2016

Presentation Fellows 2016

Antiplatelet Therapy for the Interventionalist

Presenter: Roxana Mehran

April 15, 2016

Presentation JIM 2016

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Presenter: Roxana Mehran

February 11, 2016

Presentation JIM 2016

Self- Apposing Stents in STEMI:The Stentys Experience

Presenter: Roxana Mehran

February 10, 2016

$Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?$

Presentation TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 4 Academia Perspectives

Presenter: Roxana Mehran, Laura Mauri

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Roxana Mehran, Keith D. Dawkins

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 2 EMA Perspectives

Presenter: Roxana Mehran, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 1 FDA Perspectives

Presenter: Roxana Mehran, John C Laschinger

October 13, 2015

Presentation TCT 2015

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

Presenter: Roxana Mehran, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

Presenter: Ajay J. Kirtane, Roxana Mehran, Robert A. Harrington

October 12, 2015

Advertisement

Optimal Duration of DAPT: Update on DAPT Guidelines

The Unmet Needs of DES

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antiplatelet Therapy for the Interventionalist

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Self- Apposing Stents in STEMI:The Stentys Experience

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Big Data: Opportunities and Challenges 4 Academia Perspectives

Big Data: Opportunities and Challenges 3 Industry Perspectives

Big Data: Opportunities and Challenges 2 EMA Perspectives

Big Data: Opportunities and Challenges 1 FDA Perspectives

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content